Back
Gladstone Commercial 10K Form
Buy
57
GOOD
Gladstone Commercial
Last Price:
16.97
Seasonality Move:
0.4%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
2024-05-06 | 10Q | GOOD/Gladstone Commercial Quarterly |
2023-11-06 | 10Q | GOOD/Gladstone Commercial Quarterly |
2023-08-08 | 10Q | GOOD/Gladstone Commercial Quarterly |
2023-05-03 | 10Q | GOOD/Gladstone Commercial Quarterly |
2022-11-07 | 10Q | GOOD/Gladstone Commercial Quarterly |
2022-08-01 | 10Q | GOOD/Gladstone Commercial Quarterly |
Receive GOOD News And Ratings
See the #1 stock for the next 7 days that we like better than GOOD
GOOD Financial Statistics
Sales & Book Value
Annual Sales: | $147.58M |
---|---|
Cash Flow: | $5.54M |
Price / Cash Flow: | 15.09 |
Annual Sales: | $3.86 |
Price / Book: | 4.43 |
Profitability
EPS (TTM): | 0.21000 |
---|---|
Net Income (TTM): | $21.35M |
Gross Margin: | $115.35M |
Return on Equity: | 13.45% |
Return on Assets: | 1.9% |
Gladstone Commercial Earnings Forecast
Key Gladstone Commercial Financial Ratios
- The Gross Profit Margin over the past 17 years for GOOD is 78.16%.
- The Selling, General & Administrative Expenses for GOOD have been equal to 4.55% of Gross Profit Margin.
- The Interest Expense is 748.85% of Operating Income.
- The Net Earning history of GOOD is 3.38% of Total Revenues.
- Per Share Earnings over the last 21 years have been positive in 8 years.
Gladstone Commercial Stock Price Chart
Industry, Sector and Symbol
Stock Exchange: | NASDAQ |
---|---|
Industry: | Diversified REITs |
Sector: | Real Estate |
Current Symbol: | GOOD |
CUSIP: | 376536 |
Website: | gladstonecommercial.com |
Debt
Debt-to-Equity Ratio: | 4.1 |
---|---|
Current Ratio: | 0.39 |
Quick Ratio: | 0.11 |
Price-to-Earnings
Trailing P/E Ratio: | 0 |
---|---|
Forward P/E Ratio: | 0 |
GOOD Technical Analysis vs Fundamental Analysis
Buy
57
Gladstone Commercial (GOOD)
is a Buy
Is Gladstone Commercial a Buy or a Sell?
-
Gladstone Commercial stock is rated a Buy
The current Gladstone Commercial [GOOD] share price is $17.04. The Score for GOOD is 57, which is 14% above its historic median score of 50, and infers lower risk than normal.